Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration

NCT01271270 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: Palomid 529

Sponsor

National Eye Institute (NEI)